Mr. Jonathan H. Chou, born in 1964, was appointed as an Independent Non-Executive Director on 3 September 2010.
Mr. Chou is a seasoned finance executive and advisor with over 30 years of international experience across the semiconductor, electronics, and industrial sectors. He was most recently Chief Financial Officer of UTAC Holdings Ltd., a global provider of semiconductor assembly and test services, where he also oversaw the Group’s information technology and human resources functions.
Prior to that, he served as Chief Financial Officer of Kulicke & Soffa Industries, Inc. (Nasdaq: KLIC), a leading provider of semiconductor packaging and electronic assembly solutions, and concurrently held the position of interim Chief Executive Officer from 2015 to 2016. During his tenure, he was also responsible for the company’s global IT and facilities operations. Earlier in his career, he held senior finance leadership roles with multinational corporations including Honeywell, Tyco ADT, Lucent Technologies Bell Labs, and Public Service Enterprise Group.
Mr. Chou currently serves as an Independent Non-Executive Director of MicroPort CardioFlow Medtech Corporation, a subsidiary of the Company listed on the Hong Kong Stock Exchange. He is also Chairman of the Board of the Emerging Markets Investors Alliance, a not-for-profit organization promoting sustainable governance among institutional investors, and advises several private-equity-backed companies including AddVita Pte. Ltd., an Asian healthcare distribution platform backed by SeaTown (a Temasek-linked fund).
Mr. Chou holds an MBA from Duke University’s Fuqua School of Business and a B.A. in Economics from the University at Buffalo. He has served since 2013 on the East Asia Regional Advisory Board of Duke University’s Fuqua School of Business.